Comment by
Yeehaw1 on Feb 09, 2021 1:55pm
can someone translate this into some price estimate.
Comment by
mrmonopoly on Feb 09, 2021 2:04pm
Based on the previous sales agreement ($20M over 28wks at 4000kits/wk), that means 12k test/wk comes out to about $2.1M/wk. My eyes nearly popped out of my head when I heard Marshall say 12000/wk....
Comment by
Leonovus2017 on Feb 09, 2021 2:11pm
12,000 kits is excellent!!! But, sp never reacts well with good information for some reason. Hope this thing moves up with financials.
Comment by
vantreehouse on Feb 09, 2021 2:31pm
IR or Marketing department needs to work on something and arrange this, the CEO just participate a meeting IR arrange, that's it and this should be expected.
Comment by
MLorenzo on Feb 09, 2021 2:48pm
On the positive side we did meet his cat. Big question, do we want to trust a cat guy as the CEO? Are we better off with a dog perosn?
Comment by
MLorenzo on Feb 09, 2021 3:34pm
https://twitter.com/byDavidGardner/status/1359215155784081414
Comment by
maryhill on Feb 09, 2021 3:06pm
This post has been removed in accordance with Community Policy
Comment by
GalAnonymous on Feb 09, 2021 3:30pm
Exactly! I've been long on CBDT for almost a year now and I think its CEO is a genius, but CBDT Q3 financials aren't even comparing to DM Q3 results... just on this basis alone and comparing their numbers with covid testing I think DM is an unrefined diamond waiting to be discovered. I can wait, but yes, we could be way higher if DM had proper marketing.
Comment by
Resilience19 on Feb 09, 2021 2:25pm
@monopoly agreed as this represents roughly $25M per quarter and continues to see demand increase. Granted Q4 will have been at a slower pace but if current pace was maintained throughout 2021 (possible given it may even increase) we're looking at roughly $100M in C-19 test revenues for 2021....Nice.